Sentinel Diagnostics acquired Eureka srl Lab Division

Sentinel Diagnostics acquired Eureka srl Lab Division

We are glad to announce that Sentinel Diagnostics (Sentinel CH. SpA), focused for 40 years on the development and production of in vitro diagnostic kits for clinical chemistry, immunochemistry, fecal testing, and molecular diagnostics, extends its expertise and activities in the field of chromatography and mass spectrometry through the acquisition of EUREKA S.r.l.- LAB DIVISION 

“This acquisition supports our plan to become an important player in the IVD assays development and production. With the extended capabilities we’ll be able to provide clinical laboratory with a wider catalogue of assays, from high throughput core lab tests to the most advanced, specialistic second level assays”, says, dr. Marco Buonaguidi, Sentinel Diagnostics’ Head of Sales and Marketing

For further information about the acquisition, please  contact us at or Eureka Lab Division at 


EUREKA S.r.l – LAB DIVISION  is an Italian company based in Chiaravalle (AN) which has been operating in IVD chromatographic market for 25 years, developing, producing and commercializing the world’s largest range of ready-to-use diagnostic kits for HPLC, GC, GC-MS, LC-MS/MS applications in the field of Special Clinical Chemistry, Therapeutic Drug Monitoring, Occupational and Forensic Toxicology.  

For further information, please visit Eureka Lab Division’s website:

 About Sentinel CH. SpA

Sentinel Diagnostics (Sentinel CH. SpA) is an innovative company that, through the development of its products, contributes to the growth of scientific knowledge and the improvement of people’s health in the diagnostic field. For 40 years, Sentinel Diagnostics, an Italian company based in Milan, has been developing and producing in vitro diagnostic devices for the most advanced Clinical Chemistry, Immunochemistry and Molecular Diagnostics platforms.